Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $233.31

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12 […]

Related Keywords

Canada ,United States ,Birgit Girshick ,Jamesc Foster ,Asia Pacific ,Citigroup ,Charles River Laboratories International Stock Performance ,Commonwealth Of Pennsylvania Public School Empls Retrmt ,Raymond James Trust ,Charles River Laboratories International ,Morgan Stanley ,Charles River Laboratories International Company Profile ,Panagora Asset Management Inc ,Research Models ,Advisor Group ,Charles River Laboratories International Inc ,Great West Life Assurance Co ,Analyst Recommendations For Charles River Laboratories International ,Jpmorgan Chase Co ,Manufacturing Solutions ,Get Free Report ,River Laboratories International ,Asset Management ,Pennsylvania Public School Empls Retrmt ,West Life Assurance ,Get Free ,Safety Assessment ,Charles River Laboratories International Daily ,Nyse Crl ,Crl ,Medical ,15986410 ,Ratings ,Consensus ,